Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Treating Relapsed and Resistant Multiple Myeloma | Clinical Trial

Study on Daratumumab, Carfilzomib, Pomalidomide, and Dexamethasone for Treating Relapsed and Resistant Multiple Myeloma | Clinical Trial | Right2Hope